Showing results (141-150 of 264) with videos related to

Sort By:
Pageof 27
Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2024
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical ResponsesOliver FitzGerald, Dafna D Gladman, Philip J Mease, et al.
Nature Reviews. Disease Primers|August 13, 2021
Psoriatic arthritisOliver FitzGerald, Alexis Ogdie, Vinod Chandran, et al.
Arthritis and Rheumatism|May 27, 2006
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritisElli Kruithof, Leen De Rycke, Bernard Vandooren, et al.
Musculoskeletal Science & Practice|November 16, 2019
Advanced musculoskeletal physiotherapy practice: The patient journey and experienceOrna Fennelly, Catherine Blake, Oliver FitzGerald, et al.
Arthritis Research & Therapy|July 7, 2017
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritisAgnes Szentpetery, Eric Heffernan, Martina Gogarty, et al.
The Journal of Rheumatology. Supplement|June 3, 2019
GRAPPA 2018 Project ReportNiti Goel, Oliver FitzGerald, Dafna D Gladman, et al.
The American Journal of Pathology|August 13, 2013
Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activityJason P McMorrow, Daniel Crean, Martina Gogarty, et al.
The Journal of Rheumatology|July 15, 2024
GRAPPA 2023 Collaborative Research Network MeetingVinod Chandran, Dafna D Gladman, Philip J Mease, et al.
Pageof 27